Literature DB >> 9742228

Activation mechanism and modification kinetics of Chinese hamster dihydrofolate reductase by p-chloromercuribenzoate.

J W Wu1, Z X Wang.   

Abstract

Substrate effects on the activation kinetics of Chinese hamster dihydrofolate reductase by p-chloromercuribenzoate (pCMB) have been studied. On the basis of the kinetic equation of substrate reaction in the presence of pCMB, all modification kinetic constants for the free enzyme and enzyme-substrate binary and ternary complexes have been determined. The results of the present study indicate that the modification of Chinese hamster dihydrofolate reductase by pCMB shows single-phase kinetics, and that changes in the enzyme activity and tertiary structure proceed simultaneously during the modification process. Both substrates, NADPH and 7,8-dihydrofolate, protect dihydrofolate reductase against modification by pCMB. In the presence of a saturating concentration of NADPH, the value of kcat for 7,8-dihydrofolate in the enzyme-catalysed reaction increased four-fold on modification of Cys-6, accompanied by a two-fold increase in Km for the modified enzyme. The utilization of the binding energy of a group to increase kcat rather than reduce Km implies that the full binding energy of the group is not realized in the formation of the enzyme-substrate complex, but is used to stabilize the enzyme-transition-state complex.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9742228      PMCID: PMC1219767          DOI: 10.1042/bj3350181

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

1.  Two theoretical problems concerning the irreversible modification kinetics of enzyme activity.

Authors:  Z X Wang
Journal:  J Theor Biol       Date:  1990-02-22       Impact factor: 2.691

2.  Antifolate-resistant Chinese hamster cells. Molecular basis for the biochemical and structural heterogeneity among dihydrofolate reductases produced by drug-sensitive and drug-resistant cell lines.

Authors:  P W Melera; J P Davide; H Oen
Journal:  J Biol Chem       Date:  1988-02-05       Impact factor: 5.157

3.  Kinetics of inactivation of creatine kinase during modification of its thiol groups.

Authors:  Z X Wang; B Preiss; C L Tsou
Journal:  Biochemistry       Date:  1988-07-12       Impact factor: 3.162

4.  Kinetics of substrate reaction during irreversible modification of enzyme activity for enzymes involving two substrates.

Authors:  Z X Wang; C L Tsou
Journal:  J Theor Biol       Date:  1987-08-07       Impact factor: 2.691

5.  Determination and analysis of urea and guanidine hydrochloride denaturation curves.

Authors:  C N Pace
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

Review 6.  Kinetics of substrate reaction during irreversible modification of enzyme activity.

Authors:  C L Tsou
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1988

7.  Expression and site-directed mutagenesis of human dihydrofolate reductase.

Authors:  N J Prendergast; T J Delcamp; P L Smith; J H Freisheim
Journal:  Biochemistry       Date:  1988-05-17       Impact factor: 3.162

8.  The structure of mouse L1210 dihydrofolate reductase-drug complexes and the construction of a model of human enzyme.

Authors:  D K Stammers; J N Champness; C R Beddell; J G Dann; E Eliopoulos; A J Geddes; D Ogg; A C North
Journal:  FEBS Lett       Date:  1987-06-22       Impact factor: 4.124

9.  L1210 dihydrofolate reductase: activation and enhancement of methotrexate sensitivity.

Authors:  T H Duffy; J K Sato; K S Vitols; F M Huennekens
Journal:  Adv Enzyme Regul       Date:  1985

10.  Crystal structure of human dihydrofolate reductase complexed with folate.

Authors:  C Oefner; A D'Arcy; F K Winkler
Journal:  Eur J Biochem       Date:  1988-06-01
View more
  1 in total

1.  Kinetic and stereochemical studies on novel inactivators of C-terminal amidation.

Authors:  J Feng; J Shi; S R Sirimanne; C E Mounier-Lee; S W May
Journal:  Biochem J       Date:  2000-09-01       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.